Reading CLX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CLX free→Reading CLX? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CLX free→
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is neutral. Earnings quality is fragile, meaning profits lack cash support. Management's recent track record has been unsteady, with frequent changes. Risk is moderate, and the sector backdrop is a headwind. Peer multiples imply a price about 18% above where it trades (it looks cheap on this basis); the read is fair, but weakening. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $96.82. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $97 CLX trades at 14× p/e, below its 18× p/e peer median. Our $119 fair value sits above the price; high confidence. Analysts: $83–$139. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 19% below a flat-multiple fair value, below our forecast of about -1%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated neutral grew net income 52% of the time over the next year (vs 61% for the rest of the cohort, n=1526).
Over the trailing year it converted 0.76x of net income into operating cash flow. Historically, Consumer Staples names rated fragile grew net income 51% of the time over the next year (vs 57% for the rest of the cohort, n=1037).
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, long-term interest rates, real (inflation-adjusted) rates, Fed net liquidity.
7 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Staples names rated volatile grew net income 42% of the time over the next year (vs 51% for the rest of the cohort, n=368).
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $2.10 → $1.66 (-20.7% / 30d). 0 raised, 2 cut, 14 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 11% of analysts rate Buy.
0 positive, 0 negative / 30d.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 1 guided quarters · 189.1% avg surprise
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$124.
How much price usually moves either way.
On a bad day, this stock has moved -$306.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,236.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Earnings results will show if Clorox can address its sales decline. This is key for growth.
Confirms one read:Earnings report shows sales growth year over year.
Confirms the other:Earnings report shows continued sales decline year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CLX yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
CEO — Linda Rendle: Ms. Rendle is stepping down as CEO for health reasons but will remain in an advisory role.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
$83.00 – $139.00 (median $110.00) · 11 analysts · as of 2026-05-01
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
A side-by-side read on sector standing, valuation, and risk versus Household Products.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
CLX Clorox | Typical Show detailsSector percentile: 69 of 100 | fair | moderate |
CL Colgate-Palmolive | Typical Show detailsSector percentile: 62 of 100 | full | moderate |
KMB Kimberly-Clark | Above typical Show detailsSector percentile: 91 of 100 | fair | moderate |
CHD Church & Dwight | Typical Show detailsSector percentile: 35 of 100 | expensive | low |
REYN Reynolds Consumer Products | Above typical Show detailsSector percentile: 91 of 100 | fair | moderate |
Not investment advice. As of 2026-06-12.
via XLP
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on integrating GOJO Industries to expand product portfolio and drive growth.
Address the decline in gross margin due to higher costs and unfavorable mix.
Focus on reversing the decline in net sales and improving market share.
Adjust expectations for EPS, now expected to decrease between 27% and 29%.
Why it matters: A bigger drop would show ongoing problems with market share and consumer demand.
Confirms:Q4 organic sales decline worse than -9% year over year.
Disproves:Q4 organic sales decline less than -9% year over year.
Why it matters: A bigger drop would show rising costs and hurt overall profits.
Confirms:Gross margin decline exceeds 300 basis points in Q4.
Disproves:Gross margin decline is less than 250 basis points in Q4.
Why it matters: A new CEO could change priorities and affect company performance and investor trust.
Confirms one read:New CEO shares a clear plan that matches market expectations.
Confirms the other:New CEO does not give a clear plan, leading to uncertainty.
Why it matters: A new CEO may change the company’s plans and actions. This affects stability.
Confirms one read:Announcement of a new CEO with a strong track record in consumer goods.
Confirms the other:No progress on the CEO search after three months.
Why it matters: Better gross margins show improved cost management. This helps the company make more money.
Confirms:Gross margin improves by more than 2% in the next quarter.
Disproves:Gross margin declines further by more than 1% in the next quarter.
Why it matters: New debt could affect Clorox's ability to invest in growth. This is key for future plans.
Confirms:Debt issuance leads to a clear plan for capital allocation that supports growth.
Disproves:Issuing debt means no new growth plans were announced.
Results of Operations and Financial Condition On April 30, 2026 , The Clorox Company issued a press release announcing its financial results for its third quarter ended March 31, 2026. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Other Events On May 6, 2026, The Clorox Company (the “Company”) executed an underwriting agreement in connection with the sale of an aggregate principal amount of $550,000,000 of its 4.700% Senior Notes due 2031 (the “2031 Notes”), an aggregate principal amount of $400,000,000 of its 4.950% Senior Notes due 2033 (the “2033 Notes”) and an aggregate principal amount of $550,000,000 of its 5.250% Senior Notes due 2036 (taken together with the 2031 Notes and the 2033 Notes, the “Securities”), in…
Other Events On April 1, 2026, Clorox completed its previously announced purchase of all of the issued and outstanding membership interests of Gojo Industries, makers of Purell ® . Clorox acquired Gojo Industries pursuant to a membership interest purchase agreement (“MIPA”), by and among Clorox, Gojo Industries Holdings, Inc. (“Parent”), Gojo Industries and the shareholders of Parent.
Entry into a Material Definitive Agreement On March 6, 2026, in connection with the purchase of all of the issued and outstanding membership interests of GOJO Industries, Inc. (“GOJO”), maker of PURELL® (the “Gojo Acquisition”), pursuant to a membership interest purchase agreement (the “Acquisition Agreement”), by and among The Clorox Company (the “Company”), GOJO Industries Holdings, Inc., GOJO and certain shareholders, the Company entered into (i) a $1,000,000,000 364-day revolving credit a…